Brinker Capital Investments’s Epizyme, Inc EPZM Stock Holding History

Brinker Capital Investments’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-11,175	Closed	-$16K	–	1418
2022 Q2	$16K	Buy	+11,175	New	+$8.21K	﹤0.01%	1344

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Brinker Capital Investments's EPZM Position: Q3 2022 in Review

Brinker Capital Investments sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 11,175 shares — an estimated $16K sold.

Brinker Capital Investments first reported a position in EPZM in Q2 2022 and held it in 1 quarter. The position peaked at $16K in Q2 2022. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

Brinker Capital Investments reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
Brinker Capital Investments sold 11,175 Epizyme, Inc shares in Q3 2022, an estimated $16K.
Brinker Capital Investments first reported a position in Epizyme, Inc in Q2 2022 and held it in 1 quarter.
Brinker Capital Investments's Epizyme, Inc position peaked at $16K in Q2 2022.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Brinker Capital Investments's 13F filing for Q3 2022, filed 1 Nov 2022.